Fundraising Fox

🦊/Companies

Neopenda

Techstars '18 Techstars '18

Chicago, US · Founded 2015 · Delaware corporation · 14 employees on LinkedIn · 6 known investors

Find your way into Neopenda

611 people in our graph share verified history with the Neopenda team — schools, employers, funds. One of them is your warm intro.

Wesley Barrowunlockedknows Sona Shah · together at Techstars (overlapped)

knows the team · via Santa Clara University

×7knows the team · via Techstars

×2knows the team · via Columbia University in the City of New York

knows the team · via Georgia Institute of Technology

Neopenda develops health-technology devices for neonatal care in emerging markets, specifically serving healthcare facilities in underserved populations. The company, structured as a public benefit corporation, focuses on innovative products to improve health outcomes in resource-limited settings.

Biotech Fintech Healthtech Impact & Social Good IoT Medical Devices

Founders & leadership

Neopenda was founded in 2015 by Sona Shah and Teresa Cauvel.

SS

Sona Shah

Sona Shah inCEO and FounderSona Shah has a background in biomedical engineering and cofounded Neopenda in 2015 after teaching primary school in Kenya, where she observed healthcare challenges in resource-limited settings. As CEO, she leads the company in developing medical technology devices for neonatal care in emerging markets.

TC

Teresa Cauvel

Teresa Cauvel inCTO and FounderTeresa Cauvel is a biomedical engineer who studied at Columbia University, where she focused on global health medical device development and tissue engineering. She founded Neopenda, a public benefit corporation developing health-technology devices for neonatal care in resource-limited settings, and has worked with healthcare facilities across Uganda and Kenya.

Board

ZS

Zachary SeavernsBoard director

Investors · 6

Connetic VenturesCovington · $250K – $500K

Founders Factory AfricaJohannesburg

TechstarsBoulder · $220K

Villgro AfricaNairobi

Sorenson Impact FoundationreportedSalt Lake City

Also in the syndicate · 1

Assiduity Capital

Funding

SEC filings, press & company announcements

$2M disclosed across 8 of 9 rounds · 2018–2026

Undisclosed amountpost-seed roundApr 2021
Assiduity Capital, Sorenson Impact Foundation
Source ↗

▶$215KraisedAug 2026 · 8 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Sona ShahExecutive Officer, Director
Zachary SeavernsDirector

Offering amount: $500K
Amount sold: $215K
Minimum investment: $5K
Proceeds to insiders: $100K
First sale: Aug 2026
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$35KraisedMay 2026 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Zachary SeavernsDirector
Teresa CauvelExecutive Officer, Director
Sona ShahExecutive Officer, Director

Offering amount: $1.5M
Amount sold: $35K
Minimum investment: $5K
Proceeds to insiders: $150K
First sale: Apr 2026
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$200KraisedNov 2024 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Sona ShahExecutive Officer, Director
Teresa CauvelExecutive Officer, Director
Zachary SeavernsDirector

Offering amount: $1.5M
Amount sold: $200K
Minimum investment: $5K
Proceeds to insiders: $375K
First sale: Nov 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$700KraisedJan 2024 · 5 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Teresa CauvelExecutive Officer, Director
Sona ShahExecutive Officer, Director
Zachary SeavernsDirector

Offering amount: $1.5M
Amount sold: $700K
Minimum investment: $10K
Proceeds to insiders: $240K
First sale: Aug 2022
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$252KraisedJun 2020 · 4 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Zachary SeavernsDirector
Teresa CauvelExecutive Officer, Director
Sona ShahExecutive Officer, Director

Offering amount: $1.7M
Amount sold: $252K
Minimum investment: $25K
Proceeds to insiders: $215K
First sale: Jun 2020
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$410KraisedMar 2019 · 3 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Sona ShahExecutive Officer, Director
Teresa CauvelExecutive Officer, Director

Offering amount: $1.3M
Amount sold: $410K
Proceeds to insiders: $180K
First sale: Feb 2019
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$125KraisedAug 2018 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Teresa CauvelExecutive Officer, Director
Sona ShahExecutive Officer, Director

Offering amount: $125K
Amount sold: $125K
Minimum investment: $25K
Proceeds to insiders: $42K
First sale: Jul 2018
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$20KraisedAug 2018 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Sona ShahExecutive Officer, Director
Teresa CauvelExecutive Officer, Director

Offering amount: $20K
Amount sold: $20K
Minimum investment: $20K
First sale: Jul 2018
Incorporated: Corporation, Delaware, 2015
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Neopenda on Wefunder 2025 - Kingscrowdkingscrowd.com · Apr 2025

Chicago Medtech Startup, Neopenda, Announces New Round of Convertible Note Financingprnewswire.com · Apr 2021

Chicago's Neopenda raises seed round to produce wearable neonatal monitors - ImpactAlphaimpactalpha.com · May 2019

Infant Mortality-Focused Healthtech Neopenda Raises USD 1 Mn From Axel Johnson Inc and SUNU Capitalweetracker.com · Apr 2019

Frequently asked questions

What does Neopenda do?: Neopenda develops health-technology devices for neonatal care in emerging markets, specifically serving healthcare facilities in underserved populations. The company, structured as a public benefit corporation, focuses on innovative products to improve health outcomes in resource-limited settings.
Who founded Neopenda?: Neopenda was founded by Sona Shah, Teresa Cauvel in 2015.
Who are Neopenda's investors?: Neopenda's investors include Connetic Ventures, Founders Factory Africa, Techstars, Villgro Africa, Sorenson Impact Foundation.
How much funding has Neopenda raised?: Neopenda has disclosed $2M raised across 8 of its 9 known rounds.
Where is Neopenda headquartered?: Neopenda is headquartered in Chicago, US.